Back to search
FDAFDA · Food and drugs·Recall number D-901-2013

Mavik® trandolapril tablets 4mg, 100 count bottle, Rx only, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ for Abbott Laboratories, North Chicago, IL 60064, USA

Published August 28, 2013 · Recall initiated: August 1, 2013

Summary

FDA records drug Class III recall D-901-2013, published August 28, 2013 and initiated August 1, 2013. Recalling firm: AbbVie Inc.; Status: Terminated; Reported quantity: 704 bottles; Lot: Lot 22033GY. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect Package Insert; product packaged with outdated version of the insert

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AbbVie Inc.
Distributor
Nationwide
Lot
Lot 22033GY
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Mavik® trandolapril tablets 4mg, 100 count bottle, Rx only, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ for Abbott Laboratories, North Chicago, IL 60064, USA recalled?

Yes. FDA published recall D-901-2013 on August 28, 2013. Reported hazard: Labeling: Incorrect Package Insert; product packaged with outdated version of the insert

What should I do if I have this product?

Voluntary: Firm initiated · Letter